Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II

Trial Profile

Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 14 May 2018

At a glance

  • Drugs Rituximab (Primary)
  • Indications Follicular lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2018 Planned End Date changed from 1 May 2027 to 1 May 2028.
    • 22 May 2013 Status changed from not yet recruiting to recruiting as reported by M.D. Anderson Cancer Center.
    • 22 May 2013 New source identified and integrated (M.D. Anderson Cancer Center: 2011-0283).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top